Related Experiment Video
Updated: Mar 18, 2026

08:51
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
10.0K
Overview and diagnosis of multiple sclerosis
1sfhunter@neurosci.us.
The American Journal of Managed Care
|June 30, 2016
Summary
Multiple sclerosis (MS) is an immune-mediated central nervous system disease causing demyelination and neurological damage. This chronic condition significantly impacts patient quality of life and healthcare systems.
Area of Science:
- Neuroimmunology
- Neurology
- Chronic Inflammatory Diseases
Background:
- Multiple sclerosis (MS) is a chronic, immune-mediated inflammatory disease affecting the central nervous system (CNS).
- Pathology involves demyelination, axonal/neuronal damage, and multifocal lesions in CNS white and gray matter.
- MS pathogenesis is complex, involving T- and B-cell mechanisms and presenting heterogeneously.
Purpose of the Study:
- To summarize the key aspects of multiple sclerosis, including its pathology, pathogenesis, and clinical impact.
- To highlight recent revisions in clinical categorization for improved disease course characterization.
- To underscore the significant burden of MS on patients, healthcare systems, and society.
Main Methods:
- Review of existing literature on multiple sclerosis.
- Analysis of pathological characteristics and immunemediated mechanisms.
- Examination of clinical manifestations and disease burden.
Main Results:
- MS leads to demyelination and neurological deficits, with characteristic MRI-visible lesions.
- Revised clinical categories aim to better classify disease progression and guide research.
- MS is a leading cause of neurological disability in young and middle-aged adults.
Conclusions:
- Multiple sclerosis presents a substantial challenge due to its chronic inflammatory nature and progressive neurological damage.
- Effective characterization and understanding of MS are crucial for managing patient care and reducing societal burden.
- Continued research is essential to address the complexities of MS pathogenesis and improve patient outcomes.
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
3.0K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.0K
Myasthenia Gravis: Overview and Treatment
3.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.3K
Formulating and Validating Nursing Diagnosis II
4.2K
Nursing diagnoses represent a problem validated by major defining characteristics. There are four categories of nursing diagnoses: problem-focused, risk, health promotion or wellness, and syndrome. The anatomy of a nursing diagnosis includes three components: problem statement or diagnostic label, defining characteristics, and related factors.
Risk nursing diagnoses represent clinical judgments of an individual, family, or community more vulnerable to developing the health problem than others...
Risk nursing diagnoses represent clinical judgments of an individual, family, or community more vulnerable to developing the health problem than others...
4.2K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
715
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
715
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K

